Advertisement
more top stories »

Cancer

— Medical

Reactivation of a single gene turns colorectal cancer cells back into normal tissue

By - June 23, 2015 2 Pictures

Future cancer treatments may target your genes rather than the cancerous cells themselves. A new study found that reactivating a single gene was enough to stop and reverse colorectal cancer (that's cancer of the colon, or bowels) in mice, with a return to normal intestinal functions within just four days and tumors gone within two weeks. The concept, though not the specific method, could lead to new treatments of a variety of cancers.

Read More
— Medical

Herpes virus genetically engineered to destroy skin cancer cells

By - May 27, 2015 1 Picture

A new study has pointed to a chink in the armor of skin cancer cells, suggesting that they can be overpowered by the body's own system with help from a pioneering approach known as viral therapy. A clinical trial has demonstrated that a genetically engineered herpes virus can not only plant itself in the cancer cells and kill them off, but activate the body's own immune system to stave off harmful tumors.

Read More
— Medical

FDA ticks off first drug to treat radiation sickness after nuclear disasters

By - May 25, 2015 1 Picture

A drug long-used to counter the negative effects of chemotherapy has won US Food and Drug Administration (FDA) approval for use in treating the nasty effects of exposure to radiation following a nuclear disaster. Known commercially as Neupogen, the drug has been shown to work by shielding the body's white blood cells to heighten a patient's chances of survival.

Read More
— Medical

Loading cancer vaccines into silicon microparticles could stop tumors in their tracks

By - May 6, 2015 1 Picture

A key battleground in the fight against cancer has been the development of vaccines to stop tumors taking hold. These are intended to kick the body's own immune system into action to fend off the cancerous cells, with immunotherapy drugs for melanomas, prostate and lung cancer all emerging in recent years. But one hurdle oncologists are yet to tackle with any great success is a vaccine for breast cancer. New research now suggests this mightn't be all that far away, with the discovery that loading cancer antigens into silicon microparticles serves to greatly boost the immune response.

Read More
Advertisement

Subscribe to Gizmag's email newsletter

Advertisement